Market Overview

The Global Aquaculture Vaccine Market was valued at USD 388.2 million in 2023 and is expected to reach USD 740.1 million by 2031 while growing at a CAGR of 8.4% during the forecast period (2024-2031). 

 *Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report

Market Dynamics

This section of the report will analyze various driving and restraining factors that are expected to have a significant impact on the global aquaculture vaccine market growth. Aquaculture vaccines are designed to trigger an immune response in fish and shrimp, preventing or controlling diseases. Vital for modern aquaculture, these vaccines are essential in environments where numerous aquatic species are farmed in confined spaces, heightening their vulnerability to infectious diseases.

Significant growth in the aquaculture vaccine market is driven by increased investment in research and development, coupled with technological advancements in vaccine development. However, challenges like regulatory hurdles and high development costs may hinder the market's expansion.

Furthermore, the global aquaculture vaccine industry will be analyzed through various tools including PESTLE analysis, and Porter’s analysis.

Segmentation – By Vaccine Type Analysis

The Global Aquaculture Vaccine Market is segmented among Live, Inactivated, and Other Vaccine Types, based on Vaccine Type. In 2023, Inactivated accounted for the majority of the market share*.

 *Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report

Segmentation – By Type of Administration Analysis

The Global Aquaculture Vaccine Market is segmented among Oral, Immersion, and Injected, based on Type of Administration. In 2023, Injected accounted for the majority of the market share*.

*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report

Global Aquaculture Vaccine Market: Regional Analysis

Based on region, the market is divided into six regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. In 2023, North America dominated the market with the highest market share, while Europe is expected to grow with the highest CAGR during the forecast period (2024 – 2031).

 *Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report

Competitive Landscape

Some of the key players operating in the market are Hipra, Merck & Co. Inc., KBNP, Nisseiken Co., Ltd., KoVax Ltd., Kyoritsuseiyaku Corporation, Elanco, Vaxxinova International BV, and Kyoto Biken Laboratories, Inc.

Table of Contents:

1. Research Methodology and Market Scope

• Research Methodology

• Market Scope

2. Executive Summary

3. Global Aquaculture Vaccine Market Dynamics

• Drivers

• Restraints

• Opportunity

4. Global Aquaculture Vaccine Industry Analysis

• PEST Analysis

• Porter's Five Force Analysis

• Recent Deals Analysis

5. Global Aquaculture Vaccine Market Segmentation, By Vaccine Type

• Global Aquaculture Vaccine Market Share Analysis, By Vaccine Type

• Global Aquaculture Vaccine Market Growth Analysis, By Vaccine Type

• Global Aquaculture Vaccine Market Trends, By Vaccine Type

o Live

o Inactivated

o Other Vaccine Types

6. Global Aquaculture Vaccine Market Segmentation, By Type of Administration

• Global Aquaculture Vaccine Market Share Analysis, By Type of Administration

• Global Aquaculture Vaccine Market Growth Analysis, By Type of Administration

• Global Aquaculture Vaccine Market Trends, By Type of Administration

o Oral

o Immersion

o Injected

7. Global Aquaculture Vaccine Market Segmentation, By Region

• Global Aquaculture Vaccine Market Share Analysis, By Region

• Global Aquaculture Vaccine Market Growth Analysis, By Region

• Global Aquaculture Vaccine Market Trends, By Region

o North America

o Europe

o Asia Pacific

o Latin America

o Middle East

o Africa

8. Competitive Landscape

• Hipra*

o Company Overview

o Financial Performance

o Key Development/Strategies

o SWOT Analysis

• Merck & Co. Inc.

• KBNP

• Nisseiken Co., Ltd.

• KoVax Ltd.

• Kyoritsuseiyaku Corporation

• Elanco

• Vaxxinova International BV

• Kyoto Biken Laboratories, Inc. 

*Similar analysis will be provided for each company listed above.